Kidney Cancer Research Summit

Personalized Neoantigen Vaccines Show Lasting Tumor Control in Kidney Cancer

July 19th 2025, 6:00pm

Article

Early data suggest personalized neoantigen vaccines activate the immune system and sustain tumor control in some patients with kidney cancer.

How Personalized Cancer Vaccines Are Advancing Kidney Cancer Care

July 18th 2025, 8:00pm

Video

Personalized cancer vaccines may potentially represent a step forward in guiding the immune system to more precisely target kidney cancer.

Research Continues for Best Immunotherapy Order in Advanced RCC

July 21st 2023, 8:00pm

Article

Even with the increase of immunotherapy utilization to treat patients with advanced renal cell carcinoma, more research is needed to determine in which order to administer it as later lines of therapy.

In Kidney Cancer Treatment, ‘Personalized Biomarkers Work’

July 20th 2023, 1:00pm

Video

Therapies that target specific characteristics on kidney cancer cells are showing promise in the space, an expert explained.

‘It’s a Time of Hope’ for Kidney Cancer

July 19th 2023, 3:00pm

Video

With new treatments being explored, it’s an exciting time for patients with kidney cancer, an expert explained.

How Cancer Teams Leverage Biology in Guiding First-Line Therapy for Clear Cell RCC

July 19th 2023, 1:00pm

Article

An expert explained what aspects of a patient’s disease cancer care teams use to determine the best treatment options for patients with clear cell renal cell carcinoma.

BAP1-Mutated RCC Responds to Treatment with Lynparza

July 18th 2023, 3:00pm

Article

Patients with BAP1-mutated renal cell carcinoma who were treated with Lynparza obtained responses with favorable side effect profiles.

New Drugs Being Explored in Kidney Cancer

July 17th 2023, 1:00pm

Article

An expert gives an overview of up-and-coming treatments for patients with kidney cancer.

Drug Duo Continues to Show Promise in Advanced Kidney Cancer

July 16th 2023, 4:00pm

Article

Long-term follow-up data showed that Lenvima plus Keytruda continued to show benefit in patients with metastatic kidney cancer.

Upfront Immunotherapy Delays Surgery, Improves Metastatic Kidney Cancer Control

July 15th 2023, 7:00pm

Article

Immunotherapy combinations tended to improve outcomes for patients with metastatic kidney cancer who go on to receive surgery.